GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ACS Global Inc (OTCPK:AMCY) » Definitions » PB Ratio

ACS Global (ACS Global) PB Ratio : (As of May. 29, 2024)


View and export this data going back to . Start your Free Trial

What is ACS Global PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-29), ACS Global's share price is $3.00. ACS Global's Book Value per Share for the fiscal year that ended in . 20 was $0.00. Hence, ACS Global's PB Ratio of today is .

The historical rank and industry rank for ACS Global's PB Ratio or its related term are showing as below:

AMCY's PB Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.125
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


ACS Global PB Ratio Historical Data

The historical data trend for ACS Global's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACS Global PB Ratio Chart

ACS Global Annual Data
Trend
PB Ratio

ACS Global Quarterly Data
PB Ratio

Competitive Comparison of ACS Global's PB Ratio

For the Diagnostics & Research subindustry, ACS Global's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ACS Global's PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, ACS Global's PB Ratio distribution charts can be found below:

* The bar in red indicates where ACS Global's PB Ratio falls into.



ACS Global PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

ACS Global's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (A: . 20)
=3.00/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


ACS Global  (OTCPK:AMCY) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


ACS Global PB Ratio Related Terms

Thank you for viewing the detailed overview of ACS Global's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ACS Global (ACS Global) Business Description

Traded in Other Exchanges
N/A
Address
1 Meridian Road, Suite 5, Eatontown, NJ, USA, 07724
ACS Global Inc is evaluating opportunities for the development of new technologies in the medical and cellular therapy industries. It is looking to identify complimentary products and services for American CryoStem human cell and tissue products (hCTPs). The company supports the ongoing research and development efforts of American CryoStem Corporation in their pursuit of FDA approval of its flagship autologous cell therapy product ATCell.

ACS Global (ACS Global) Headlines

No Headlines